Skip to main content

Monsanto Opposes Cancer Victim’s Quick Trial Request

Monsanto Opposes Cancer Victim’s Quick Trial Request

Monsanto Opposes Cancer Victim’s Quick Trial Request

Introduction

On November 16, attorneys representing a plaintiff in a lawsuit filed against Monsanto company requested U.S District Judge Vince Chhabria for an expedited trial as the plaintiff has less than six months to live as per his oncologist. On Friday, November 30, Monsanto told the California federal judge the dying man should not be granted a fast-track trial. The lawsuit filed on behalf of the 66-year-old California resident stated he was diagnosed with non-Hodgkin's lymphoma (NHL) due to exposure to glyphosate-containing weed killer Roundup.

The second bellwether trial case selected is the lawsuit filed by a plaintiff, which is scheduled to go for trial on February 25, 2019. A California couple allegedly affected by Roundup's adverse effects was granted an expedited trial by Superior Court Judge Ioana Petrou in Oakland last month; the case will head to trial on March 18, 2019, in California.

Several individuals affected by Roundup herbicides have sued the agricultural company in California, Missouri, and Delaware state courts. Multidistrict litigation has been formed in the U.S. District Court, Northern District of California, overlooked by Judge Vince Chhabria.

Monsanto has a brief history of legal troubles and Glyphosate is just another herbicide of the company to attract lawsuits. Plaintiffs across the U.S. have filed numerous lawsuits. IARC, considered to be the apex in the field of cancer research, classified glyphosate as a “probable human carcinogen.” According to IARC, Roundup is made up of other ingredients that are toxic in themselves, and are also known to increase the toxicity of glyphosate. Monsanto has known this for many years but still refuses to study the link between cancer and Roundup.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!